Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by (18)F-FDG PET/CT

Tonsillar carcinoma is the second most common malignancy of the head and neck region, with Squamous Cell Carcinoma (TSCC) as the most common histological type (>90%). For the advanced stage of TSCC, radiotherapy with or without platinum-based chemotherapy is the only therapeutic option. Immuno-ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Niccoli Asabella, Artor, Nappi, Anna Giulia, Trani, Orsola, Sardaro, Angela, Rubini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Interesting Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922132/
https://www.ncbi.nlm.nih.gov/pubmed/33669822
http://dx.doi.org/10.3390/diagnostics11020348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922132/
https://www.ncbi.nlm.nih.gov/pubmed/33669822
http://dx.doi.org/10.3390/diagnostics11020348

Ejemplares similares